2013
DOI: 10.1542/peds.2013-0224
|View full text |Cite
|
Sign up to set email alerts
|

Characteristics of Pain in Children and Youth With Cerebral Palsy

Abstract: WHAT'S KNOWN ON THIS SUBJECT: Pain in children with cerebral palsy is underrecognized and undertreated and negatively affects quality of life. Communication challenges and multiple pain etiologies complicate management. There is a wide range of pain prevalence reported in the literature (14% to 73%). WHAT THIS STUDY ADDS:The impact of pain on activities in children with cerebral palsy across a wide age range and motor abilities is investigated. Physician-identified causes of pain are systematically assessed an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

13
219
1
7

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 184 publications
(251 citation statements)
references
References 27 publications
(27 reference statements)
13
219
1
7
Order By: Relevance
“…Professionals should use different treatment strategies for every child, i.e., an individual combination of pharmacological substances and complementary methods that include psychological, social, and physical strategies such as physiotherapy (Nilsson, EnskĂ€r, Hallqvist, & Kokinsky, 2013;Penner, Xie, Binepal, Switzer, & Fehlings, 2013). As orally administered medication does not always reduce pain in children with CP, alternatives could be implemented with other types of medication, such as continuous intrathecal baclofen (CITB) therapy (Vles et al, 2013) or botulinum toxin type-A (BoNT-A; Williams et al, 2013).…”
Section: Literature Reviewmentioning
confidence: 99%
“…Professionals should use different treatment strategies for every child, i.e., an individual combination of pharmacological substances and complementary methods that include psychological, social, and physical strategies such as physiotherapy (Nilsson, EnskĂ€r, Hallqvist, & Kokinsky, 2013;Penner, Xie, Binepal, Switzer, & Fehlings, 2013). As orally administered medication does not always reduce pain in children with CP, alternatives could be implemented with other types of medication, such as continuous intrathecal baclofen (CITB) therapy (Vles et al, 2013) or botulinum toxin type-A (BoNT-A; Williams et al, 2013).…”
Section: Literature Reviewmentioning
confidence: 99%
“…8 Children with more severe motor impairments may experience pain stemming from musculoskeletal changes (eg, hip subluxation/ dislocation, fragility fractures secondary to a reduction in bone mass), neurologic issues (eg, hypertonia, spasticity, dystonia), gastrointestinal issues (eg, gastro esophageal reflux), and/or assistive equipment (eg, uncomfortable seating). 6,9 This is not to say that children at lower levels of GMFCS do not experience chronic pain. Previous estimates suggest that pain is experienced by upwards of 60% of children with CP who can self-report, and as high as 73% of children when report is provided by a caregiver proxy.…”
mentioning
confidence: 99%
“…8,10 Within a Canadian context, 1 in 4 children with CP have moderate to severe pain and in some cases, report multiple sources of pain. 9 The vast heterogeneity of the CP condition, as well as multiple potential sources of pain and varied communicative abilities hampers accurate assessment; this often leaves pain unrecognized and untreated. 9,11,12 Unrecognized pain can have negative implications on health and quality of life, with the possibility that childhood pain will persist and progress into adulthood.…”
mentioning
confidence: 99%
See 2 more Smart Citations